351 related articles for article (PubMed ID: 29524592)
1. Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
Birch D; Diedrichsen RG; Christophersen PC; Mu H; Nielsen HM
Eur J Pharm Sci; 2018 Jun; 118():144-153. PubMed ID: 29524592
[TBL] [Abstract][Full Text] [Related]
2. Biorelevant media resistant co-culture model mimicking permeability of human intestine.
Antoine D; Pellequer Y; Tempesta C; Lorscheidt S; Kettel B; Tamaddon L; Jannin V; Demarne F; Lamprecht A; Béduneau A
Int J Pharm; 2015 Mar; 481(1-2):27-36. PubMed ID: 25601199
[TBL] [Abstract][Full Text] [Related]
3. Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation.
Boegh M; García-Díaz M; Müllertz A; Nielsen HM
Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):136-43. PubMed ID: 25622791
[TBL] [Abstract][Full Text] [Related]
4. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
5. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
Béduneau A; Tempesta C; Fimbel S; Pellequer Y; Jannin V; Demarne F; Lamprecht A
Eur J Pharm Biopharm; 2014 Jul; 87(2):290-8. PubMed ID: 24704198
[TBL] [Abstract][Full Text] [Related]
6. Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption.
Boegh M; Baldursdóttir SG; Müllertz A; Nielsen HM
Eur J Pharm Biopharm; 2014 Jul; 87(2):227-35. PubMed ID: 24413146
[TBL] [Abstract][Full Text] [Related]
7. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
[TBL] [Abstract][Full Text] [Related]
8. Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae.
Maher S; Feighery L; Brayden DJ; McClean S
Pharm Res; 2007 Jul; 24(7):1346-56. PubMed ID: 17380268
[TBL] [Abstract][Full Text] [Related]
9. HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer.
Pontier C; Pachot J; Botham R; Lenfant B; Arnaud P
J Pharm Sci; 2001 Oct; 90(10):1608-19. PubMed ID: 11745719
[TBL] [Abstract][Full Text] [Related]
10. 3D Model Replicating the Intestinal Function to Evaluate Drug Permeability.
Pereira I; Lechanteur A; Sarmento B
Methods Mol Biol; 2018; 1817():107-113. PubMed ID: 29959707
[TBL] [Abstract][Full Text] [Related]
11. Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl)amino]octanoate (SNAC).
Mortensen JS; Bohr SS; Harloff-Helleberg S; Hatzakis NS; Saaby L; Nielsen HM
J Control Release; 2022 Dec; 352():163-178. PubMed ID: 36314534
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs.
Antunes F; Andrade F; Araújo F; Ferreira D; Sarmento B
Eur J Pharm Biopharm; 2013 Apr; 83(3):427-35. PubMed ID: 23159710
[TBL] [Abstract][Full Text] [Related]
13. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
Schimpel C; Teubl B; Absenger M; Meindl C; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
Mol Pharm; 2014 Mar; 11(3):808-18. PubMed ID: 24502507
[TBL] [Abstract][Full Text] [Related]
14. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
[TBL] [Abstract][Full Text] [Related]
15. Mucus interactions with liposomes encapsulating bioactives: Interfacial tensiometry and cellular uptake on Caco-2 and cocultures of Caco-2/HT29-MTX.
Li Y; Arranz E; Guri A; Corredig M
Food Res Int; 2017 Feb; 92():128-137. PubMed ID: 28290290
[TBL] [Abstract][Full Text] [Related]
16. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
17. A drug absorption model based on the mucus layer producing human intestinal goblet cell line HT29-H.
Wikman A; Karlsson J; Carlstedt I; Artursson P
Pharm Res; 1993 Jun; 10(6):843-52. PubMed ID: 8321852
[TBL] [Abstract][Full Text] [Related]
18. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
Schipper NG; Vârum KM; Stenberg P; Ocklind G; Lennernäs H; Artursson P
Eur J Pharm Sci; 1999 Aug; 8(4):335-43. PubMed ID: 10425384
[TBL] [Abstract][Full Text] [Related]
19. Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies.
Araújo F; Sarmento B
Int J Pharm; 2013 Dec; 458(1):128-34. PubMed ID: 24120728
[TBL] [Abstract][Full Text] [Related]
20. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans.
Walter E; Janich S; Roessler BJ; Hilfinger JM; Amidon GL
J Pharm Sci; 1996 Oct; 85(10):1070-6. PubMed ID: 8897273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
